MedTrace Logo

A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED

NCT04313842 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-03-18

No results posted yet for this study

Summary

This is an exploratory study to evaluate the clinical feasibility of medical deivce 'AVATAMED' for predicting the clinical response to TMZ (temozolomide) in glioblasotma patients.

Conditions

Interventions

DEVICE

AVATAMED

tumor specimen will be sent for in vitro drug screening experiment and the result will be analyzed by 'AVATAMED' to predict the clinical response

Sponsors & Collaborators

  • Doo-Sik Kong

    lead OTHER

Principal Investigators

  • Doo-sik Kong, MD PhD · Professor

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2021-06-01
Completion
2022-01-01

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04313842 on ClinicalTrials.gov